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Abstract
Background  and  objective:  We  compared  the  efﬁcacy  of  intravenous  (IV)  paracetamol  versus
dipyrone  via  patient-controlled  analgesia  (PCA)  for  postoperative  pain  relief  in  children.
Methods:  The  study  was  composed  of  120  children  who  had  undergone  elective  tonsillectomy
after receiving  general  anesthesia.  Patients  were  divided  into  3  groups  according  to  the  dosage
of postoperative  intravenous-patient-controlled  analgesia:  paracetamol,  dipyrone,  or  placebo.
Pain was  evaluated  using  a  0-  to  100-mm  visual  analog  scale  and  1-  to  4-pain  relief  score  at
30 min,  1,  2,  4,  6,  12,  and  24  h  postoperatively.  Pethidine  (0.25  mg  kg−1)  was  administered
intravenously  to  patients  requiring  rescue  analgesia.  Pethidine  requirements  were  recorded
during the  ﬁrst  24  h  postoperatively,  and  treatment  related  adverse  effects  were  noted.
Results:  Postoperative  visual  analog  scale  scores  were  signiﬁcantly  lower  with  paracetamol
group compared  with  placebo  group  at  6  h  (p  <  0.05),  dipyrone  group  compared  with  placebo
group at  30  min  and  6  h  (p  <  0.05).  No  signiﬁcant  differences  regarding  visual  analog  scale  values
at 1,  2,  4,  12,  and  24  h  were  found.  No  signiﬁcant  differences  were  found  between  groups  with
respect to  pain  relief  score  (p  >  0.05).  Postoperative  pethidine  requirements  were  signiﬁcantly
lower with  paracetamol  and  dipyrone  groups  compared  with  placebo  group  (62.5%,  68.4%  vs
90%, p  <  0.05).  No  signiﬁcant  differences  were  found  between  groups  with  respect  to  nausea,
vomiting  and  the  any  other  adverse  effects  of  the  drugs  (p  >  0.05).
Conclusions:  Paracetamol  and  dipyrone  have  well  tolerability  proﬁle  and  effective  analgesic
properties  when  administered  IV-PCA  for  postoperative  analgesia  in  children  after  tonsillectomy.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
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Administrac¸ão de  paracetamol  versus  dipirona  em  analgesia  controlada  pelo  paciente
por  via  intravenosa  para  alívio  da  dor  no  pós-operatório  de  crianc¸as após
tonsilectomia
Resumo
Justiﬁcativa  e  objetivo:  Comparamos  a  eﬁcácia  da  administrac¸ão  de  paracetamol  versus
dipirona em  analgesia  controlada  pelo  paciente  (PCA)  por  via  intravenosa  (IV)  para  alívio  da
dor no  período  pós-operatório  em  crianc¸as.
Métodos:  O  estudo  foi  composto  por  120  crianc¸as  submetidas  à  tonsilectomia  sob  anestesia
geral. Os  pacientes  foram  divididos  em  três  grupos  de  acordo  com  a  dose  IV  de  analgesia  con-
trolada pelo  paciente  no  pós-operatório:  paracetamol,  dipirona  ou  placebo.  A  dor  foi  avaliada
usando uma  escala  visual  analógica  de  0-100  mm  e  escore  de  1-4  para  alívio  da  dor  nos  tempos
de 30  minutos,  1,  2,  4,  6,  12  e  24  horas  de  pós-operatório.  Petidina  (0,25  mg  kg−1)  foi  admin-
istrada IV  aos  pacientes  que  precisaram  de  analgesia  de  resgate.  A  necessidade  de  petidina  foi
registrada  durante  as  primeiras  24  h  de  pós-operatório,  e  os  efeitos  adversos  relacionados  ao
tratamento  foram  registrados.
Resultados:  Os  escores  da  escala  visual  analógica  no  pós-operatório  foram  signiﬁcativamente
menores  no  grupo  paracetamol  em  comparac¸ão  com  o  grupo  placebo  em  6  h  (p  <  0,05),  no  grupo
dipirona em  comparac¸ão  com  o  grupo  placebo  em  30  min  e  6  h  (p  <  0,05).  Não  houve  diferenc¸a
signiﬁcativa  em  relac¸ão  aos  valores  da  escala  visual  analógica  nos  tempos  avaliados  de  1,  2,  4,
12 e  24  horas.  Não  houve  diferenc¸a signiﬁcativa  entre  os  grupos  quanto  ao  escore  de  alívio  da
dor (p  >  0,05).  A  necessidade  de  petidina  foi  signiﬁcativamente  menor  nos  grupos  paracetamol
e dipirona  em  comparac¸ão  com  o  grupo  placebo  (62,5%,  68,4%  vs.  90%,  p  <  0,05).  Não  houve
diferenc¸a signiﬁcativa  entre  os  grupos  em  relac¸ão  à  incidência  de  náusea,  vômito  e  outros
efeitos adversos  dos  medicamentos  (p  >  0,05).
Conclusões:  Paracetamol  e  dipirona  possuem  um  perﬁl  de  boa  tolerabilidade  e  propriedades
analgésicas  eﬁcazes  quando  administrados  IV  para  ACP  no  pós-operatório  de  crianc¸as  após
tonsilectomia.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
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Introduction
Tonsillectomy  can  be  considered  as  the  most  widely
practiced  one  among  the  childhood  surgical  operations.  Suf-
ﬁcient  treatment  of  postoperative  pain  in  children  is  a  main
concern  for  patients,  parents  and  clinicians.1 However,  suc-
cessful  treatment  of  postoperative  pain  in  children  is  still
difﬁcult  despite  of  recent  progress  in  control  technique  of
pain  and  analgesics.  Insufﬁcient  postoperative  pain  control
can  result  in  impairment  of  the  feature  of  life,  recov-
ery  of  patients  and  social  stress  for  both  the  children  and
the  parents.1 Analgesics  such  as  opioids  and  non-opioids
are  frequently  used  for  postoperative  pain  management.
The  severity  of  side  effects  related  with  effective  opioid
dosage  may  restrict  their  usage  for  sufﬁcient  postopera-
tive  pain  control.  Intravenous  (IV)  non-opioid  analgesics
are  used  extensively  for  the  treatment  of  postoperative
pain.  Non-opioid  analgesics  have  been  shown  to  effec-
tively  decrease  postoperative  pain,  opioid  consumption
and  thus  their  adverse  effects  during  the  postoperative
period  in  children.2 There  are  only  a  few  alternative  anal-
gesic  agents  for  IV  non-opioid  analgesia  for  the  treatment
of  postoperative  pain  in  pediatric  patient.2 Paracetamol
(acetaminophen)2--6 and  dipyrone  (metamizol)7--9 are  two
10,11frequently  used  IV  non-opioid  analgesics. Paracetamol
is  the  most  popular,  effective  and  most  widely  used  non-
opioid  analgesic  for  acute  pain.11 Dipyrone  has  potent
pain-relieving,  antipyretic,  spasmolytic  properties,  and  is
M
T
Ulso  an  effective  non-opioid  analgesic  for  acute  pain.11
aracetamol  and  dipyrone  generally  show  similar  clinical
fﬁcacy.5,12 On  the  other  hand,  administration  of  paracet-
mol  resulted  in  a  signiﬁcant  reduction  in  the  number  of
atients  requiring  opioid  analgesics  to  achieve  adequate
ostoperative  pain  relief  when  compared  with  dipyrone.13
V-PCA  is  an  effective  method  for  the  treatment  of  post-
perative  pain  both  in  adults  and  children.2 IV-PCA  is  an
ffective  and  safe  method  providing  appropriate  levels  of
nalgesia  in  children  over  5  years  of  age.14,15 The  literature
eview  reveals  that  there  are  a  few  studies  conducted  with
on-opioid  analgesics  by  IV-PCA  for  treatment  of  postopera-
ive  pain  in  only  adults.16--21 Although  non-opioid  analgesics
paracetamol  and  dipyrone)  are  widely  used  in  the  pediatric
ge  group,  surprisingly  we  have  not  seen  any  report  con-
erning  non-opioid  analgesic  (paracetamol  or  dipyrone)  use
ia  IV-PCA  for  postoperative  pain  treatment  in  children.
In  our  study,  we  aimed  to  test  the  hypothesis  that  IV-
CA  with  paracetamol  for  treatment  of  postoperative  pain
n  children  after  tonsillectomy  is  superior  and  an  acceptable
lternative  for  dipyrone  by  IV-PCA  in  terms  of  an  adequate
ostoperative  pain  relief  and  reduction  in  the  number  of
atients  requiring  opioid  analgesics.ethods
he  protocol  was  approved  by  the  Ethics  Committee  of
niversity  Faculty  of  Medicine  (project  no:  KA08/47).
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178  
ritten  informed  parental  consent  and  verbal  child  assent
ere  obtained  from  143  ASA  I  patients  (according  to  the
merican  Society  of  Anesthesiologists  Physical  Status  Classi-
cation  system;  aged  7--15  years)  who  had  been  scheduled
or  elective  tonsillectomy.  The  study  was  a  prospective,
andomized,  placebo-controlled  double-blind  study.
atients  were  instructed  how  to  use  a  PCA  pump  prior  to
urgery  and  were  informed  about  the  data  to  be  collected
ostoperatively  using  a  visual  analog  scale  (VAS)  and  pain
elief  score  (PRS).  Exclusion  criteria  included  a  history  of
igniﬁcant  hepatic,  pulmonary,  renal,  or  cardiac  disease;
ypersensitivity  to  the  study  medications;  any  disorder
ontraindicating  administration  of  non-opioid  analgesics;
eptic  ulcer  disease;  asthma;  a  bleeding  disorder;  concomi-
ant  medication  (anticonvulsants,  corticosteroids,  psycho
ropics,  or  antihistamines);  intolerance  to  non-opioids.
hose  unable  to  understand  the  instructions  regarding
he  use  of  PCA  were  not  included  in  the  study.  Patients
ere  not  allowed  to  receive  any  analgesics  24  h  prior  to
he  operation.  Patients  were  assigned  randomly  to  1  of
 study  groups,  according  to  a  pre-generated  randomiza-
ion  scheme  created  by  the  web  site  Randomization.com
http://www.randomization.com),  to  receive  IV-PCA
reatment  with  paracetamol,  dipyrone,  or  placebo  (0.9%
aCl).
The  analgesic  solution  (500  mL  0.9%  NaCl)  was  prepared
y  one  of  the  researchers  (AK)  blinded  to  the  treatment
rotocol  and  not  involved  in  the  intraoperative  and  post-
perative  patient  treatment.  Patients  were  blind  to  the
reatment.  Postoperative  data  were  collected  by  another
nesthesiologist  (EC)  blinded  as  to  which  analgesic  was  used.
he  solutions  contained  either  2  mg  mL−1 paracetamol,
 mg  mL−1 dipyrone,  or  1  mL  normal  saline.  No  premedi-
ation  was  given  to  the  children.  General  anesthesia  was
nduced  with  thiopental  (5--7  mg  kg−1),  fentanyl  (1  g  kg−1),
nd  vecuronium  (0.1  mg  kg−1).  After  tracheal  intubation,
echanical  ventilation  was  initiated,  and  a  50%  mixture  of
2O/O2 was  administered  throughout  the  surgery.  Anesthe-
ia  was  maintained  with  isoﬂurane  1.2  MAC.  Residual  muscle
elaxation  was  reversed  with  neostigmine  and  atropine  at
he  end  of  the  operation.  All  patients  were  extubated  in
he  operating  room.  Patients  were  assigned  to  one  of  the
ollowing  3  groups  with  respect  to  the  analgesic  agent
dministered  via  IV-PCA  (Abbott  Pain  Management  Provider,
bbott  Laboratories,  Abbott  Park,  Ill,  USA)  in  the  recovery
oom:
Paracetamol:  Loading  dose  of  4.5  mg  kg−1 IV,  followed  by
0.5  mg  kg−1 h−1 basal  infusion,  1  mg  kg−1 bolus  dose,  lock-
out  time  30  min  for  24  h  (total  dose  of  paracetamol  was
limited  to  10  mg  kg−1 4  h−1).
Dipyrone:  Loading  dose  of  4.5  mg  kg−1 IV,  followed  by
0.5  mg  kg−1 h−1 basal  infusion,  1  mg  kg−1 bolus  dose,  lock-
out  time  30  min  for  24  h  (total  dose  of  dipyrone  was  limited
to  10  mg  kg−1 4  h−1).
Placebo:  Loading  dose  of  2  mL  kg−1 IV,  followed  by
0.5  mL  kg−1 h−1 basal  infusion,  1  mL  kg−1 bolus  dose,  lock-
out  time  30  min.Postoperative  pain  intensity  was  evaluated  by  the  patient
ccording  to  a  0-  to  100-mm  horizontal  VAS  at  30  min,  1,  2,  4,
,  12,  and  24  h  postoperatively.  PRS  (Pain  Relief  Score)  was
t
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valuated  by  the  patient  according  to  a  0 =  none,  1  =  little,
 =  some,  3  =  a  lot,  and  4  = complete  relief  at  30  min,  1,  2,  4,
,  12,  and  24  h  postoperatively.  Pethidine  (0.25  mg  kg−1)  was
iven  IV  to  patients  whose  VAS  score  was  ≥40  mm  and/or
RS  was  <2  and  then  recorded  (total  dose  of  pethidine
as  limited  to  1.5  mg  kg−1 6  h−1).  Adverse  effects  including
ausea,  vomiting,  bleeding  at  the  surgical  ﬁeld,  dyspepsia,
llergic  reactions,  and  use  of  antiemetic  medication  (meto-
lopramide  HCl)  also  were  recorded  during  the  ﬁrst  24  h
ostoperatively.
A  power  analysis  was  performed  based  on  the  total  pethi-
ine  requirement  data  obtained  from  the  ﬁrst  15  patients
n  the  placebo  group.  The  results  of  the  ﬁrst  15  patients
n  the  placebo  group  showed  that  mean  total  pethidine
equirement  was  0.81  ±  0.39  mg  kg−1 during  the  ﬁrst  24  h
ostoperatively.  If  we  also  assumed  a  two-tailed  type  I  error
f  0.05  and  a  power  of  0.80,  approximately  40  patients  in
ach  group  were  required  in  order  to  detect  a  30%  reduc-
ion  in  the  dose  of  total  pethidine  requirement  between  the
roups.  Analysis  was  performed  by  Power  and  Precision  V4
M  (version  4.1.0,  Biostat  Inc.,  Englewood,  NJ)  statistical
rogram.
All  statistical  calculations  were  performed  using  SPSS  for
indows  software  (Statistical  Package  for  the  Social  Sci-
nces,  version  11.0,  SSPS  Inc,  Chicago,  IL,  USA).  Differences
etween  the  3  groups  were  analyzed  using  an  analysis  of
ariance  (ANOVA)  test  or  its  nonparametric  counterpart,
he  Kruskal--Wallis  test.  Post  hoc  analysis  was  performed
sing  the  Bonferroni  test.  Homogeneity  of  variances  was
alculated  using  Levene’s  test  and  Lilliefors  signiﬁcance  cor-
ection.  Chi-square  or  Fisher’s  exact  tests  were  used  to
nalyze  categorical  variables  where  appropriate.  Data  are
xpressed  as  means  ±  SD.  Differences  were  considered  sta-
istically  signiﬁcant  at  levels  of  p  <  0.05.
esults
ne  hundred  and  forty  three  children  were  screened  to  par-
icipate  in  this  study.  During  screening  8  patients  were  found
o  be  not  eligible  for  the  study,  9  patients’  parents  declined
o  give  consent  and  6  patients  were  excluded  due  to  other
easons.  Finally,  a total  of  120  patients  constituted  the  study
opulation  (Fig.  1).  The  demographic  characteristics  and
peration  time  of  the  groups  were  found  similar  (Table  1).
AS  values  for  the  dipyrone  group  (39.8  ±  31.9  mm)  were
igniﬁcantly  lower  than  those  of  the  placebo  group
56.6  ±  27.2  mm)  at  30  min  postoperatively  (p  =  0.044).  VAS
alues  for  the  paracetamol  group  (17.5  ±  15.8  mm)  and  dipy-
one  group  (20.9  ±  22.4  mm)  were  signiﬁcantly  lower  than
hose  of  the  placebo  group  (30.1  ±  23.3  mm)  at  6  h  postop-
ratively  (paracetamol  versus  placebo;  p  =  0.013,  dipyrone
ersus  placebo;  p  =  0.045).  No  statistically  signiﬁcant  differ-
nces  were  found  between  the  groups  in  terms  of  VAS  values
,  2,  4,  12,  and  24  h  postoperatively  (p  > 0.05  at  each  time
oint,  Table  2).  No  statistically  signiﬁcant  differences  were
ound  between  the  groups  in  terms  of  PRS  values  30  min,
,  2,  4,  6,  12,  and  24  h  postoperatively  (p  >  0.05  at  each
ime  point,  Fig.  2).  No  statistically  signiﬁcant  difference  was
ound  in  the  cumulative  amounts  of  non-opioid  analgesics
onsumed  by  the  patients  (paracetamol  955.1  ±  497.8  mg
nd  dipyrone  832.1  ±  375.9  mg,  p  >  0.05).
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Enrollment
Allocation
Follow-Up
Analysis
Assessed for eligibility (n=143)
Excluded (n=23)
♦ Not meeting inclusion criteria (n=8)
♦ Declined to participate (n=9)
♦ Other reasons (n=6)
♦ Did not receive placebo (n=0)
♦ Received placebo (n=40)
Placebo(n=40)
Discontinued dipyrone (n=0)
Lost to follow-up (n=0)
Discontinued placebo (n=0)
Lost to follow-up (n=0)
Discontinued paracetamol (n=0)
Lost to follow-up (n=0)
Analysed (n=0) Analysed (n=0) Analysed (n=0)
♦ Did not receive dipyrone (n=0)
♦ Received dipyrone (n=40)
Dipyrone (n=40)Paracetamol (n=40)
♦ Received paracetamol (n=40)
♦ Did not receive paracetamol (n=0)
♦ Excluded from analysis (n=0) ♦ Excluded from analysis (n=0) ♦ Excluded from analysis (n=0)
Randomized (n=120)
Figure  1  Enrolment  process.
Table  1  Demographic  and  baseline  clinical  characteristics  of  the  patients.
Paracetamol  (n  =  40)  Dipyrone  (n  =  40)  Placebo  (n  =  40)
Age  (year)  9.4  ±  2.2  8.8  ±  2.2  9.2  ±  2.3
Weight (kg)  33.2  ±  12.9  30.6  ±  11.1  32.2  ±  12.3
Sex (male/female,  n)  20/20  20/19  23/17
Duration of  surgery  (min)  39.1  ±  15.4  43.0  ±  13.0  37.3  ±  13.9
Values are means ± SD or numbers of patients, as appropriate.
Table  2  Mean  pain  scores  (VAS)  for  each  of  the  indicated  times.
Paracetamol  (n  =  40)  Dipyrone  (n  =  40)  Placebo  (n  =  40)  p
VAS  30  min.  40.4  ±  30.6  39.8  ±  31.9a 56.6  ±  27.2a 0.044a
VAS  1  h  16.8  ±  18.8  21.8  ±  11.1  24.1  ±  25.5  0.340
VAS 2  h  16.4  ±  15.0  28.1  ±  26.2  23.5  ±  25.3  0.173
VAS 4  h  18.3  ±  15.9  26.1  ±  28.5  26.1  ±  25.3  0.645
VAS 6  h  17.5  ±  15.8b 20.9  ±  22.4a 30.1  ±  23.3a,b 0.045a/0.013b
VAS  12  h  19.6  ±  18.1  16.1  ±  15.4  24.5  ±  24.9  0.549
VAS 24  h  11.9  ±  11.7  11.2  ±  8.9  19.4  ±  19.1  0.244
Data are mean ± SD. VAS, visual analog scale (VAS values obtained from each group were compared with the other treatments at each
time point using an analysis of variance).
a p < 0.05, dipyrone versus placebo.
b p < 0.05, paracetamol versus placebo.
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and  allergic  reactions  were  not  recorded  during  the  ﬁrst
24  h  postoperatively.  With  respect  to  adverse  effects,  no
signiﬁcant  difference  was  found  among  the  groups  studied
(p  >  0.05).
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Discussion
Our  study  revealed  that  the  administration  of  paracetamol
and  dipyrone  by  IV-PCA  for  the  treatment  of  acute  postop-
erative  pain  resulted  in  a  well  tolerability  and  had  similar
effective  analgesic  properties  in  children  after  tonsillec-
tomy.  The  rescue  opioid  analgesic  requirement  during  the
ﬁrst  24  h  after  surgery  was  signiﬁcantly  lower  in  the  paracet-
amol  and  dipyrone  groups  when  compared  with  the  placebo
group.
IV-PCA  is  an  effective  method  used  for  the  treatment
of  postoperative  pain  in  adults  and  children,  while  regu-
lating  the  dose  according  to  individual  needs,  and  its  use
has  expanded  to  even  young  children.2,14,15 In  some  of  the
studies,18--21 dipyrone  was  successfully  used  in  adults  by
IV-PCA  for  postoperative  pain  management.  Although,  IV
paracetamol  and  dipyrone  are  widely  used  in  children,  we
have  not  encountered  any  report  concerning  paracetamol  or
dipyrone  use  by  IV-PCA  for  postoperative  pain  treatment  for
this  group  of  age.  Our  study  is  the  ﬁrst  prospective,  random-
ized,  double-blind,  placebo-controlled  study  to  compare
IV-PCA  with  paracetamol  and  dipyrone  for  postoperative
pain  management  in  children.  Further  studies  may  be  warr-
anted  with  various  doses  of  paracetamol  and  dipyrone  to
deﬁne  the  optimum  IV-PCA  regimen  for  postoperative  pain
management  in  children.
Why  do  practitioners  administer  IV  non-opioids  inter-
mittently  by  bolus  injection  with  hand-held  injector  for
acute  postoperative  pain  treatment  in  patients  that  already
receives  intra-operatively  non-opioids  intravenously  and
then  continued  every  6  h  for  24  h?  Markedly  high  and  low
levels  of  analgesic  drugs  may  result  as  suboptimal  manage-
ment  of  postoperative  pain  with  the  intermittent  IV  bolus
technique.  We  think  that  IV  non-opioid  analgesics  should
be  administered  by  IV-PCA  for  acute  postoperative  pain
treatment  when  appropriate.  Non-opioid  analgesics  admin-
istered  via  IV-PCA  should  have  well  tolerability  properties
and  low  incidences  of  adverse  effects.  Paracetamol  is  a
safe  and  well  tolerated  drug  with  minor  adverse  effects
and  proven  efﬁcacy  when  used  perioperatively.22--24 IV  para-
cetamol  has  signiﬁcantly  increased  the  use  of  perioperative
analgesic.22--24 IV  form  of  paracetamol  seems  to  result  in  a
better  analgesic  effect  when  compared  with  other  forms.6
Dipyrone  is  a  widely  used  effective  analgesic  with  low
adverse  effects.2 In  our  study,  adverse  effects  including  per-
sistent  nausea  and  vomiting,  bleeding  at  the  surgical  ﬁeld,
dyspepsia,  and  allergic  reactions  were  not  encountered  dur-
ing  the  ﬁrst  24  h  postoperatively.  In  addition  to  this,  the
incidence  of  nausea,  vomiting  and  the  need  for  antiemetic
medication  were  similar  in  study  drugs  and  placebo  groups.
In  our  study,  we  are  surprised  that  there  is  no  difference  in
the  incidence  of  side  effects  in  the  placebo,  paracetamol,
and  dipyrone  groups.  Since  the  placebo  group  consumed  sig-
niﬁcantly  more  pethidine  than  the  other  groups.  We  would
have  expected  a  lower  incidence  of  nausea  and  vomiting  in
the  two  PCA  groups  since  they  consumed  less  pethidine.  We
think  that  the  incidence  of  postoperative  nausea  and  vomi-
ting  (PONV)  is  not  only  related  to  study  medication  but  it  is
also  related  to  the  type  of  surgery  as  tonsillectomy.  Para-
cetamol  and  dipyrone  are  relatively  well  tolerated  agents
when  compared  with  the  other  non-opioid  analgesics  with
respect  to  potential  side  effects.25,26 We  did  not  encounter
F
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ny  complication  related  with  paracetamol  and  dipyrone
ithout  PONV.  IV  dipyrone  and  paracetamol  are  commonly
sed  non-opioid  analgesics  as  the  primary  analgesic  or  adju-
ant  to  opioid  analgesia  for  postoperative  pain  management
n  childhood  in  our  country.
IV  paracetamol  and  tramadol  have  similar  analgesic  prop-
rties  after  adenotonsillectomy  in  children.3 Dipyrone  and
ramadol  can  be  considered  as  alternative  analgesics  for
reatment  of  postoperative  pain  when  administered  by  IV-
CA.20 IV  dipyrone  has  been  revealed  to  be  an  effective
nalgesic6,18--21,27 and  has  equivalent  efﬁcacy  to  that  of  IV
aracetamol  for  postoperative  pain  treatment5,12 Korkmaz
ilmen  et  al.28 demonstrated  that  IV  paracetamol  and  dipy-
one  provide  effective  analgesia  after  lumbar  disk  surgery
hen  administrated  as  rescue  analgesic  with  morphine  by
CA.  On  the  other  hand,  Grundmann  et  al.25 showed  that
ipyrone  is  superior  to  paracetamol  for  acute  postopera-
ive  pain  treatment.  However,  their  postoperative  follow  up
eriod  was  limited  to  2  h  and  was  relatively  short  when  com-
ared  with  our  study.  In  our  study,  pain  scores  in  paracetamol
nd  dipyrone  groups  were  low  and  similar  over  the  course  of
he  assessment  period  and  the  difference  between  the  two
roups  with  respect  to  rescue  analgesic  requirement  was
ot  signiﬁcant.  Our  results  suggest  that  administration  of
aracetamol  and  dipyrone  by  IV-PCA  are  both  effective  and
ave  similar  analgesic  properties  for  the  treatment  of  acute
ostoperative  pain  following  tonsillectomy  in  children.
PONV  are  frequent  postoperative  problems  following
eneral  anesthesia  especially  after  tonsillectomy.  Use  of
pioid  analgesic  is  an  important  factor  in  increasing  risk
f  PONV.  The  risk  of  PONV  depends  on  many  other  factors
uch  as  the  patient,  technique  of  the  anesthesia,  type  of
urgery,  and  medications  administered.29 In  addition  to  this,
wallowed  blood  and  oropharyngeal  irritation  induce  vomi-
ing  after  tonsillectomy  in  children.30 Adenotonsillectomy
as  the  highest  rate  of  PONV  (54%)  among  the  most  com-
only  performed  operations  in  children.31 Brodner  et  al.5
emonstrated  that  episodes  of  nausea  and  vomiting  were
ot  signiﬁcant  in  the  paracetamol  and  dipyrone  group  when
ompared  with  placebo  group  after  minor  to  intermediate
urgery.  They  show  that  the  incidence  of  side  effects  was  not
igniﬁcant  among  the  groups;  the  range  of  relative  frequen-
ies  for  nausea  was  between  30.6%  and  42.9%  and  the  range
f  relative  frequencies  for  vomiting  was  between  18.4%  and
4.5%.8 Uysal  et  al.3 showed  that  the  frequency  of  nausea
nd  vomiting  are  22%  and  19%  respectively  in  IV  paraceta-
ol  group  after  adenotonsillectomy  in  children.  In  our  study,
ausea  developed  in  15.8%  patients  and  vomiting  in  29.2%,
ut  those  were  the  only  adverse  effects  experienced  by  our
atients.  Our  results  revealed  ﬁndings  similar  to  those  of
revious  studies,  and  we  think  that  the  incidence  of  PONV
s  not  only  related  to  study  medication  but  it  is  also  related
o  the  type  of  surgery.
In  conclusion,  both  paracetamol  and  dipyrone  have  good
olerability  proﬁle  and  have  effective  analgesic  properties
hen  administered  by  IV-PCA  for  postoperative  analgesia
fter  tonsillectomy  in  children.unding
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